Loading provider…
Loading provider…
Dermatology Physician in Oakbrook Terrace, IL
NPI: 1366601312Primary Practice Location
Loyola Ambulatory Surgery Center at Oakbrook LP
1 Oakbrook Ter, Oakbrook Terrace, IL
Primary Employer
Summit Dermatology and Aesthetic Surgery Ltd
oakbrookdermatology.hush.com
HQ Phone
Get M.D. Rania's Phone Numberphone_androidMobile
Get M.D. Rania's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
2010 - 2026
MI State Medical License
2010 - 2026
IN State Medical License
2005 - 2025

American Board of Dermatology
Dermatology
Beeson Aesthetic Surgery Institute
Fellowship • Aesthetic and Cosmetic Surgery
2009 - 2010
Advocate Health Care/Advocate Lutheran General Hospital
Internship • Internal Medicine
2002 - 2003
Chicago Medical School at Rosalind Franklin University of Medicine and Science
Medical School
Until 2002
Indiana University School Of Medicine
medicine.iu.edu
Residency • Dermatology
2006 - 2009
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 216 | 424 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 146 | 146 |
| 3 | 17000Destruction of skin growth | 93 | 153 |
| 4 | 17110Destruction of up to 14 skin growths | 70 | 100 |
| 5 | 17003Destruction of 2-14 skin growths | 62 | 342 |
Authors: Robert Haber, Aaron Farberg, Kevin Crawford, Jeffrey Stricker, Randy Heysek
Journal: Geriatrics (Basel)
Publication Date: 2024-09-05
The art and science of oral examination.
Authors: Ginat Mirowski
Journal: Dermatol Ther
Lead Sponsor: Verrica Pharmaceuticals Inc.
Collaborators: Instat Consulting, Inc., Paidion Research, Inc., Database Integrations, Inc.
Intervention / Treatment: COMBINATION_PRODUCT: Placebo -Topical Film Forming Solution without VP-102, COMBINATION_PRODUCT: VP-102 - Cantharidin, Topical Film Forming Solution
Lead Sponsor: Elorac, Inc.
Intervention / Treatment: DRUG: Placebo tablets, DRUG: Finasteride 23.5 mg tablets, DRUG: Finasteride 33.5 mg tablets